Authors: Plaxe, SC Blessing, JA Lucci, JA Hurteau, JA

Citation: Sc. Plaxe et al., A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix - A Gynecologic Oncology Group study, INV NEW DR, 19(1), 2001, pp. 77-80

Authors: de las Alas, MM Christen, RD Gately, DP Weiner, DE Benbatoul, K Kirmani, S D'Agostino, HR Plaxe, SC Darrah, D McClay, EF Aebi, S Howell, SB Los, G

Citation: Mm. De Las Alas et al., Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel, CANC CHEMOT, 45(5), 2000, pp. 381-388

Authors: Gooding, JM D'Agostino, HB Plaxe, SC

Citation: Jm. Gooding et al., Transcervical metallic stents for drainage of uterine collections, J VAS INT R, 10(5), 1999, pp. 629-633

Authors: Aebi, S Schnider, TW Los, G Heath, DD Darrah, D Kirmani, S McClay, EF D'Agostino, H Plaxe, SC Fink, D De las Alas, MM Howell, SB Christen, RD

Citation: S. Aebi et al., A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel, CANC CHEMOT, 44(3), 1999, pp. 259-265

Authors: Plaxe, SC Saltzstein, SL

Citation: Sc. Plaxe et Sl. Saltzstein, Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening, GYNECOL ONC, 75(1), 1999, pp. 55-61